GTG supplies non-coding patents to NZ’s Ovita
Monday, 28 June, 2004
Melbourne gene-test company Genetic Technologies (ASX:GTG) has granted a license to New Zealand agbiotech company Ovita Limited to apply GTG’s non-coding DNA patents to its own internal activities.
In an announcement today, GTG said the license would allow the Dunedin company to use the gene-testing technology both for its in-house research, and future commercial activities.
Ovita will pay GTG an up-front signing fee and royalties on future sales.
The Ovita license is the second GTG has granted in New Zealand. GTG’s executive chairman Dr Merv Jacobson said GTG will support the growth and future success of Ovita by offering similar licenses to Ovita’s research partners and commercial collaborators.
Jacobson said GTG stood ready to offer its assistance and technology to other New Zealand organisations to support the efficiency and quality of the country’s agricultural output.
Last month GTG subsidiary AgGenomics signed a contract with Ovita to provide genetic testing services on DNA samples from Australian and New Zealand sheep, through its high-throughput DNA-testing laboratory at Melbourne’s La Trobe University.
Targeting the stress system reduces Parkinson's tremors
The commonly used Parkinson's drug levodopa usually helps with tremors, but it tends to be...
DDX53 gene linked to autism spectrum disorder
While DDX53, located on the X chromosome, is known to play a role in brain development...
ADHD drug shows promise for treating meth addiction
A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be...
